Research analysts at StockNews.com began coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a research note issued on Sunday. The brokerage set a “hold” rating on the software maker’s stock.
Veradigm Stock Down 1.4 %
Shares of NASDAQ:MDRX opened at $10.66 on Friday. The business has a 50-day moving average of $9.62 and a two-hundred day moving average of $9.33. Veradigm has a fifty-two week low of $5.01 and a fifty-two week high of $12.86.
Institutional Trading of Veradigm
An institutional investor recently bought a new position in Veradigm stock. Innealta Capital LLC acquired a new position in Veradigm Inc. (NASDAQ:MDRX – Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 3,974 shares of the software maker’s stock, valued at approximately $38,000.
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
See Also
- Five stocks we like better than Veradigm
- What is the Euro STOXX 50 Index?
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Find and Profitably Trade Stocks at 52-Week Lows
- Time to Load Up on Home Builders?
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
